2008, Volume 15, Issue 02, pages 57-112
IN BRIEF
Br J Cardiol 2008;15:71
News in brief from the world of...
Read More
BOOK REVIEW
Br J Cardiol 2008;15:73-4
Echocardiography: Oxford specialist handbook in cardiology is an invaluable tool in the diagnosis and management of patients with cardiac disease. This new Oxford Handbook is...
Read More
BOOK REVIEW
Br J Cardiol 2008;15:75
This handbook is a comprehensive and practical overview of all aspects of electrophysiology. It covers fundamentals such as the set-up of an electrophysiology laboratory and...
Read More
OBLIQUE VIEW
Br J Cardiol 2008;15:76–7
We continue our series in which Consultant Interventionist Dr Michael Norell takes a sideways look at life in the cath lab… and beyond. In this...
Read More
CLINICAL ARTICLE
Br J Cardiol 2008;15:79–81
Familial hypercholesterolaemia is a common genetic disorder that remains under-recognised. At present a simple genetic test is not available, although targeted genetic screening is being...
Read More
CLINICAL ARTICLE
Br J Cardiol 2008;15:83-85
Low-density lipoprotein (LDL)-apheresis is the treatment of choice in homozygous familial hypercholesterolaemia as well as various other severe dyslipidaemic conditions. However, it appears to be...
Read More
CLINICAL ARTICLE
Br J Cardiol 2008;15:87-94
Anticoagulant therapy plays a key role in pharmacological reperfusion therapy for acute ST segment elevation myocardial infarction (STEMI). Until recently, the established role of unfractionated...
Read More
CLINICAL ARTICLE
Br J Cardiol 2008;15:95-100
Data from 101 practices that had completed a survey of cholesterol target achievement using rosuvastatin in routine general practice were pooled to assess effectiveness at...
Read More
CLINICAL ARTICLE
Br J Cardiol 2008;15:101-5
The Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) showed that addition of eplerenone to optimal medical therapy reduced morbidity and mortality...
Read More
CLINICAL ARTICLE
Br J Cardiol 2008;15:106-9
Achieving a lower heart rate is important in treating angina. Established approaches include the use of beta blockers and certain calcium channel blockers. However, the...
Read More
CLINICAL ARTICLE
Br J Cardiol 2008;15:110
A 63-year-old gentleman presented with palpitations and a sensation of chest fullness. He had previously undergone laparoscopic oesophageal...
Read More
EDITORIAL
Br J Cardiol 2008;15:63-4
So now we know ... drug-eluting stents (DES) are not to vanish from our armoury at the whim of a National Institute for Health and...
Read More
EDITORIAL
Br J Cardiol 2008;15:65-6
In recent years, general practitioners (GPs) have been swamped by the burden of diabetes in the UK. The incidence has been growing almost as fast...
Read More
NEWS
Br J Cardiol 2008;15:68-9
The National Institute for Health and Clinical Excellence (NICE) has recommended that drug-eluting stents can continue to be used in patients who have a higher...
Read More
NEWS
Br J Cardiol 2008;15:68-9
The results of two major trials of intensive glucose lowering in patients with type 2 diabetes appear to have reached different...
Read More
CLINICAL ARTICLE
Br J Cardiol 2008;15:111–2
Dextrocardia is a rare anomaly with an estimated prevalence of about one in 10,000. The incidence of coronary artery disease is the same as in...
Read More
NEWS
Br J Cardiol 2008;15:68-9
In contrast, the ADVANCE study, has not shown any harm in its intensive treatment arm. In this trial, 11,140 high-risk patients with type 2 diabetes,...
Read More
NEWS
Br J Cardiol 2008;15:68-9
A new study has highlighted a changing pattern of cardiovascular mortality within Europe, and shows that while cardiovascular mortality rates are decreasing in general, Eastern...
Read More